# ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies

> **NCT07191730** · — · RECRUITING · sponsor: **University Hospital, Caen** · enrollment: 600 (estimated)

## Conditions studied

- Cardiotoxicity
- Heart Failure
- Neoplasms
- Breast Neoplasms

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07191730
- **Lead sponsor:** University Hospital, Caen
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-29
- **Primary completion:** 2028-03
- **Final completion:** 2028-11
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2026-03-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07191730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07191730, "ML Score Prediction of Cardiotoxicity in Cancer Patients Receiving Anthracycline Chemotherapy or HER2-Targeted Therapies". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07191730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*